← Browse by Condition
Medical Condition
myasthenia gravis
Total Trials
9
Recruiting Now
9
Trial Phases
Phase 1, Phase 2, Phase 3, Phase 2, Phase 3
NCT06006832
Recruiting
A Prospective Cohort Study of Myasthenia Gravis in China
Enrollment
202 pts
Location
China
Sponsor
Peking Union Medical College H...
NCT06106672 Phase 1, Phase 2
Recruiting
Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in Subjects With Myasthenia Gravis
Enrollment
54 pts
Location
United States
Sponsor
COUR Pharmaceutical Developmen...
NCT04951622 Phase 3
Recruiting
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
Enrollment
199 pts
Location
United States, Austr...
Sponsor
Janssen Research & Development...
NCT05337891
Recruiting
Sensitivity of Repetitive Nerve Stimulation Performed in the Evening vs in the Morning in Myasthenia Gravis
Enrollment
40 pts
Location
Poland
Sponsor
Jagiellonian University
NCT06193889 Phase 2, Phase 3
Recruiting
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis
Enrollment
66 pts
Location
United States, Brazi...
Sponsor
Kyverna Therapeutics
NCT07294170
Recruiting
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
Enrollment
70 pts
Location
United States
Sponsor
argenx
NCT06414954 Phase 2
Recruiting
Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
Enrollment
84 pts
Location
United States, Belgi...
Sponsor
NMD Pharma A/S
NCT01793168
Recruiting
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Enrollment
20,000 pts
Location
United States, Austr...
Sponsor
Sanford Health
NCT07022197 Phase 1, Phase 2
Recruiting
Safety and Efficacy of BAFF-R CART for Refractory Neuroimmune Diseases
Enrollment
27 pts
Location
China
Sponsor
Tianjin Medical University Gen...